PURPOSE Use of the T cell-dependent neoantigen bacteriophage ΦX 174 has been described since the 1960s as a method to assess specific antibody response in patients with primary immunodeficiencies. We reviewed a cohort of patients at Duke University Medical Center who received immunization with bacteriophage and report the clinical utility and safety of the immunization, as well as patient chara...

Intravenous immunoglobulin replacement therapy represents the standard treatment for hypogammaglobulinemia secondary to B-cell lymphoproliferative disorders. Subcutaneous immunoglobulin infusion is an effective, safe and well-tolerated treatment approach in primary immunodeficiencies but no extensive data are available on their use in secondary hypogammaglobulinemia, a frequent phenomenon occur...

common variable immunodeficiency (cv id) is a heterogeneous primary immunodeficiency disorder, characterized by hypogammaglobulinemia and increased susceptibility to recurrent bacterial infections. to determine the spectrum of infectious complications in patients with common variable immunodeficiency (cv id), we reviewed the hospital records of 64 cvid patients, who were diagnosed in children&a...

Answer: b. Extragenital M. hominis infections classically occur in patients who present with hypogammaglobulinemia, have received a solid-organ transplant, or recently undergone surgery (postoperative infections). There is no literature precedent for an association between neutropenia, obesity